Howard Hang is an American chemist and a professor of chemistry and chemical biology at Stanford University. He is recognized for his contributions to the development of bioorthogonal chemistry, particularly the tetrazine–trans‑cyclooctene ligation, and for applying these chemical tools to imaging, drug delivery, and the design of covalent inhibitors. Hang leads the Hang Laboratory, which focuses on chemical biology approaches to interrogate and modulate biological systems.
Education and Academic Positions
- Holds a doctoral degree (Ph.D.) in chemistry; specific institution and year are not detailed here.
- Serves as a faculty member in the Department of Chemistry at Stanford University, where he also holds appointments in related interdisciplinary programs.
Research Contributions
- Pioneered fast, catalyst‑free bioorthogonal reactions that enable rapid labeling of biomolecules in living systems.
- Developed tetrazine‑based probes for pretargeted imaging and therapeutic applications.
- Investigated covalent inhibitor design, contributing to strategies for targeting previously “undruggable” proteins.
Commercial Endeavors
- Co‑founder of biotechnology companies that translate his laboratory’s chemical biology technologies into therapeutic and diagnostic platforms.
Recognition
- Recipient of competitive research grants and awards supporting innovative chemical biology research; specific award titles are not enumerated in this summary.
Professional Impact
Howard Hang’s work has advanced the field of chemical biology by providing robust tools for site‑specific molecular labeling and by expanding the chemical strategies available for drug discovery. His research is frequently cited in the scientific literature and has influenced both academic investigations and commercial development in biotechnology.
